Moderna forecasts 15% to 25% 2026 revenue growth and targets $8.1B to $8.3B year-end cash
FROM THE WIRE · SEEKINGALPHA.COM
Moderna Q3 2026 earnings: revenue rose 29%, guidance was raised, and oncology updates advanced.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishStrong revenue growth and a raised guidance can support the Moderna share price in the near term.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna forecasts 2026 revenue growth between 15% and 25%.
- 02The company targets year-end cash between $8.1 billion and $8.3 billion.
- 03Third-quarter revenue rose 29% and guidance was raised.
- 04Oncology updates also advanced.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets